SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-22-023082
Filing Date
2022-02-14
Accepted
2022-02-14 17:01:29
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm226690d1_5.html 5  
1 OWNERSHIP DOCUMENT tm226690d1_5.xml 5 6654
  Complete submission text file 0001104659-22-023082.txt   8235
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Issuer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PHARMATHENE, INC ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401
Business Address
GILL JOHN (Reporting) CIK: 0001409939 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-32587 | Film No.: 22634220